Ke Zhu

851 total citations
33 papers, 594 citations indexed

About

Ke Zhu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ke Zhu has authored 33 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Ke Zhu's work include Immunotherapy and Immune Responses (4 papers), Peptidase Inhibition and Analysis (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Ke Zhu is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Peptidase Inhibition and Analysis (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Ke Zhu collaborates with scholars based in China, United States and Iran. Ke Zhu's co-authors include Fuqiang Shao, Kun Wang, Ziyang Zhu, Dawei Jiang, Xiaoli Lan, Chunxia Qin, Yangmeihui Song, Ruijie Qian, Zhongwen Qi and Huihui Jiang and has published in prestigious journals such as Biomaterials, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Ke Zhu

31 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Zhu China 17 214 136 116 89 81 33 594
Arpita Vyas United States 11 222 1.0× 72 0.5× 174 1.5× 87 1.0× 43 0.5× 22 616
Hsin‐Yu Fang United States 13 255 1.2× 236 1.7× 142 1.2× 66 0.7× 102 1.3× 33 780
Sanaz Keshavarz Shahbaz Iran 13 181 0.8× 138 1.0× 51 0.4× 163 1.8× 39 0.5× 32 634
Xiaohong Xu China 10 237 1.1× 124 0.9× 252 2.2× 126 1.4× 48 0.6× 26 962
Kazem Mashayekhi Iran 12 212 1.0× 152 1.1× 57 0.5× 123 1.4× 31 0.4× 26 623
Yan Hou China 11 236 1.1× 92 0.7× 99 0.9× 44 0.5× 57 0.7× 27 606
Wenping Lü China 14 198 0.9× 78 0.6× 149 1.3× 44 0.5× 45 0.6× 51 542
Conghui Liu China 10 339 1.6× 190 1.4× 67 0.6× 94 1.1× 187 2.3× 15 788
Sarra Setrerrahmane China 10 412 1.9× 164 1.2× 213 1.8× 75 0.8× 57 0.7× 15 1.0k
Maria Principia Scavo Italy 19 394 1.8× 64 0.5× 89 0.8× 125 1.4× 70 0.9× 57 877

Countries citing papers authored by Ke Zhu

Since Specialization
Citations

This map shows the geographic impact of Ke Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Zhu more than expected).

Fields of papers citing papers by Ke Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Zhu. The network helps show where Ke Zhu may publish in the future.

Co-authorship network of co-authors of Ke Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Zhu. A scholar is included among the top collaborators of Ke Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Zhu. Ke Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chao, et al.. (2025). Albiflorin improves osteoporotic bone regeneration by promoting osteogenesis-angiogenesis coupling of bone marrow mesenchymal stem cells. Biochemical and Biophysical Research Communications. 754. 151551–151551. 1 indexed citations
2.
3.
Wang, Kun, Ke Zhu, Zhiyi Yuan, et al.. (2025). Cardiomyocyte mitochondria targeted biomimetic nanozyme system with calcium ion chelating agent to treat myocardial ischemia–reperfusion injury model in mice. Chemical Engineering Journal. 517. 164177–164177. 1 indexed citations
4.
5.
Wang, Kun, Yu Sun, Ke Zhu, et al.. (2024). Anti-pyroptosis biomimetic nanoplatform loading puerarin for myocardial infarction repair: From drug discovery to drug delivery. Biomaterials. 314. 122890–122890. 14 indexed citations
6.
7.
Zhu, Jing, et al.. (2024). Enhancing breast cancer treatment: mesoporous dopamine nanoparticles in synergy with chrysin for photothermal therapy. Frontiers in Oncology. 14. 1427858–1427858. 3 indexed citations
8.
9.
10.
Zhu, Ke, Dawei Jiang, Kun Wang, et al.. (2022). Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT. Journal of Nanobiotechnology. 20(1). 211–211. 42 indexed citations
11.
Deng, Wen, Ke Zhu, Ru Chen, et al.. (2022). Novel circular RNA circ_0086722 drives tumor progression by regulating the miR-339-5p/STAT5A axis in prostate cancer. Cancer Letters. 533. 215606–215606. 23 indexed citations
12.
Shao, Fuqiang, Yu Long, Ziyang Zhu, et al.. (2022). Nectin-4-targeted immunoSPECT/CT imaging and photothermal therapy of triple-negative breast cancer. Journal of Nanobiotechnology. 20(1). 243–243. 46 indexed citations
13.
Wang, Yutong, Ke Zhu, Yangmeihui Song, et al.. (2022). Noninvasive Monitoring of Reparative Fibrosis after Myocardial Infarction in Rats Using 68Ga-FAPI-04 PET/CT. Molecular Pharmaceutics. 19(11). 4171–4178. 21 indexed citations
14.
Yan, Qing, Haoming Lin, Ke Zhu, et al.. (2022). Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma. Frontiers in Oncology. 12. 810269–810269. 21 indexed citations
15.
Deng, Wen, Gongxian Wang, Huanhuan Deng, et al.. (2021). The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma. International Journal of General Medicine. Volume 14. 9773–9787. 7 indexed citations
16.
Li, Meng, Zhongwen Qi, Junping Zhang, Ke Zhu, & Yueyao Wang. (2021). Effect and Mechanism of Si-Miao-Yong-An on Vasa Vasorum Remodeling in ApoE−/− Mice with Atherosclerosis Vulnerable Plague. Frontiers in Pharmacology. 12. 634611–634611. 18 indexed citations
17.
Zhang, Yaqin, Hui Li, Hua‐Hong Wu, et al.. (2020). [Survey on the stunting of children under seven years of age in nine cities of China].. PubMed. 58(3). 194–200. 2 indexed citations
18.
Xu, Juntao, Xiaoru Duan, Feng Hu, et al.. (2017). Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Journal of Dermatological Science. 89(2). 127–135. 44 indexed citations
19.
Liu, Xinxin, Xin Wang, Xiaoru Duan, et al.. (2017). Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis. Scientific Reports. 7(1). 7100–7100. 43 indexed citations
20.
Hu, Rong, Ying Yang, Zhuogang Liu, et al.. (2014). The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation. Tumor Biology. 36(2). 769–777. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arpita Vyas Breakdown of academic impact, for papers by Hsin‐Yu Fang Breakdown of academic impact, for papers by Sanaz Keshavarz Shahbaz Breakdown of academic impact, for papers by Xiaohong Xu Breakdown of academic impact, for papers by Kazem Mashayekhi Breakdown of academic impact, for papers by Yan Hou Breakdown of academic impact, for papers by Wenping Lü Breakdown of academic impact, for papers by Conghui Liu Breakdown of academic impact, for papers by Sarra Setrerrahmane Breakdown of academic impact, for papers by Maria Principia Scavo
Rankless by CCL
2026